Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing new Tapestri Platform updates including lowered input threshold and expanded heme-onc menu. Learn More
X
Scientific presentation

Leveraging multi-omics approaches to understand hematopoietic stem cells in myeloid malignancies


Stephen Chung, MD, University of Texas Southwestern
Description

Understanding the mechanisms that allow clonal hematopoietic stem cells (HSCs) to expand and cause disease will be critical for developing strategies to identify patients at high risk for adverse clinical outcomes who may benefit from pre-emptive interventions. A major limitation to such studies is the fact that clonal HSCs are often present at low frequencies and intermixed with their unmutated counterparts. Stephen Chung, MD, of the University of Texas Southwestern Medical Center discusses his team’s efforts to overcome this limitation by identifying cell surface markers present on clonal HSCs that will allow them to prospectively purify them for further functional and molecular studies.



VIEW


Scientific presentation
Women in Single Cell: Elucidating Clonal Evolution and Clonotype-Immunophenotype Relationships in Myeloid Malignancies with Single-Cell Analysis
Linde Miles, PhD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Meet the Authors: Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies
Ross Levine, MD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Utilizing Single-Cell Multi-Omics to Uncover its Evolution and Resistance Mechanisms of AML
Cathy Smith, MD, UCSF
(2021)
Scientific presentation
A New Single-Cell Sequencing and Analysis Platform to Accelerate Cell and Gene Therapy Pipelines
Matt Cato & Shu Wang, Mission Bio
(2021)
REQUEST QUOTE